Epicur Pharma
Daniel Kestyus is a seasoned professional in the field of pharmaceutical and research sciences, currently serving as the Lead Process Engineer at Epicur Pharma since July 2024. Prior experience includes roles at Experic as a Scientist in Technical Operations and previously as a Scientist/Jr. Engineer. Daniel worked at Syneos Health as an Associate Research Scientist and held a position as a Scientist at Johnson & Johnson, focusing on material solution sciences and manufacturing support. Prior to these roles, Daniel was a Laboratory Technician in R&D at Colgate-Palmolive, managing stability studies for dental gel and rinse formulas, and began a research career as an Undergraduate Researcher at Rider University in circadian biology and metabolism. Daniel holds a Bachelor’s Degree in Biochemistry from Rider University, obtained in 2017.
Epicur Pharma
Epicur Pharma, a division of Stokes Healthcare, manufactures drugs such as Tacrolimus Eyedrops, Buprenorphine Injection and Gabapentin tablets. Epicur is overseen by the FDA and is a leading 503B Registered Outsourcing Facility with one of the largest product portfolios for animal health.